SLS - SELLAS Life Sciences Group, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/1/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
19.68M11.62M21.84M27.52M5.80M
Enterprise Value 3
13.06M4.56M13.03M15.16M3.69M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
2.441.912.051.923.82
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-0.77-1.12-2.80-3.62-0.92

Trading Information

Stock Price History

Beta (5Y Monthly) 1.73
52-Week Change 3-72.20%
S&P500 52-Week Change 35.18%
52 Week High 312.5000
52 Week Low 31.4600
50-Day Moving Average 33.2859
200-Day Moving Average 32.7482

Share Statistics

Avg Vol (3 month) 3195.81k
Avg Vol (10 day) 3167.41k
Shares Outstanding 56.72M
Float 6.29M
% Held by Insiders 12.08%
% Held by Institutions 114.53%
Shares Short (Jun 14, 2020) 4189.07k
Short Ratio (Jun 14, 2020) 40.8
Short % of Float (Jun 14, 2020) 42.82%
Short % of Shares Outstanding (Jun 14, 2020) 42.81%
Shares Short (prior month May 14, 2020) 4262.52k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Nov 07, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-66.16%
Return on Equity (ttm)-343.23%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-27.2M
Diluted EPS (ttm)-6.7310
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.75M
Total Cash Per Share (mrq)1
Total Debt (mrq)123k
Total Debt/Equity (mrq)1.53
Current Ratio (mrq)2.42
Book Value Per Share (mrq)1.20

Cash Flow Statement

Operating Cash Flow (ttm)-19.48M
Levered Free Cash Flow (ttm)-13.17M